A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors (Q33397502)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors
scientific article

    Statements

    A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors (English)
    0 references
    7754-7764

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit